Dimitrios Nikas: Stroke During TAVI Procedures Still Remains Noticeable High
Dimitrios Nikas, President of Working Group in Stroke at Hellenic Society of Cardiology, reposted from ESC Council on Stroke on LinkedIn:
”Stroke during TAVI procedures, still remains noticeable high, despite devices and techniques evolution.
ESC Council on Stroke continues to search, develop and propose new methods to reduce the burden of stroke during interventional procedures.”
ESC Council on Stroke shared on LinkedIn about a recent article by Dimitrios N. Nikas et al, published in Journal of Clinical Medicine:
”Stroke remains a key complication after TAVI, with major impact on morbidity and mortality.
This review summarizes incidence, mechanisms, and risk factors, and highlights evolving prevention strategies, including cerebral protection devices.
Reducing stroke risk remains a central challenge in contemporary TAVI.”
Title: Stroke in Transcatheter Aortic Valve Implantation (TAVI): A Comprehensive Review
Authors: Dimitrios N. Nikas, Lampros Lakkas, Sotirios Nikopoulos, Konstantinos Samis, Xenofon Sakellariou, Matilda Florentin, Panagiotis Papanagiotou, Katerina K. Naka, George Ntaios, Lampros Michalis
Read the Full Article on Journal of Clinical Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events